{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:04:12Z","timestamp":1791198252790,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T00:00:00Z","timestamp":1436313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T00:00:00Z","timestamp":1436313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/leu.2015.176","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T06:40:54Z","timestamp":1436337654000},"page":"124-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression"],"prefix":"10.1038","volume":"30","author":[{"given":"A","family":"Mayado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Teodosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A C","family":"Garcia-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Matito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rodriguez-Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mu\u00f1iz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Jara-Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"\u00c1lvarez-Twose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Sanchez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Matarraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J I","family":"Mu\u00f1oz-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,8]]},"reference":[{"key":"BFleu2015176_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-2559.1979.tb03017.x","volume":"3","author":"K Lennert","year":"1979","unstructured":"Lennert K, Parwaresch MR . Mast cells and mast cell neoplasia: a review. Histopathology 1979; 3: 349\u2013365.","journal-title":"Histopathology"},{"key":"BFleu2015176_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2004.02.045","volume":"114","author":"P Valent","year":"2004","unstructured":"Valent P, Sperr WR, Schwartz LB, Horny HP . Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. J Allergy Clin Immunol 2004; 114: 3\u201311, quiz 2.","journal-title":"J Allergy Clin Immunol"},{"key":"BFleu2015176_CR3","doi-asserted-by":"publisher","first-page":"45S","DOI":"10.1111\/1523-1747.ep12469022","volume":"96","author":"DD Metcalfe","year":"1991","unstructured":"Metcalfe DD . The liver, spleen, and lymph nodes in mastocytosis. J Invest Dermatol 1991; 96: 45S\u201346S.","journal-title":"J Invest Dermatol"},{"key":"BFleu2015176_CR4","first-page":"54","volume-title":"World Health Organization (WHO) Classification of Tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"HP Horny","year":"2008","unstructured":"Horny HP, Metcalfe DD, Bennet JM, Bain BJ, Akin C, Escribano L et alMastocytosis. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al eds World Health Organization (WHO) Classification of Tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. International Agency for Research on Cancer (IARC): Lyon, 2008; pp 54\u201363."},{"key":"BFleu2015176_CR5","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","volume":"108","author":"AC Garcia-Montero","year":"2006","unstructured":"Garcia-Montero AC, Jara-Acevedo M, Teodosio C, Sanchez ML, Nunez R, Prados A et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 2006; 108: 2366\u20132372.","journal-title":"Blood"},{"key":"BFleu2015176_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2141.2007.06619.x","volume":"138","author":"A Orfao","year":"2007","unstructured":"Orfao A, Garcia-Montero AC, Sanchez L, Escribano L . Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br J Haematol 2007; 138: 12\u201330.","journal-title":"Br J Haematol"},{"key":"BFleu2015176_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaci.2004.04.046","volume":"114","author":"C Akin","year":"2004","unstructured":"Akin C, Metcalfe DD . The biology of Kit in disease and the application of pharmacogenetics. J Allergy Clin Immunol 2004; 114: 13\u201319, quiz 20.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"BFleu2015176_CR8","doi-asserted-by":"publisher","first-page":"168-178.e1","DOI":"10.1016\/j.jaci.2015.05.008","volume":"137","author":"Iv\u00e1n \u00c1lvarez-Twose","year":"2016","unstructured":"Alvarez-Twose I, Jara-Acevedo M, Morgado JM, Garc\u00eda-Montero AC, S\u00e1nchez-Mu\u00f1oz L, Teod\u00f3sio C et al. Clinical, immunophenotypical and molecular characteristics of well-differentiated systemic mastocytosis. J Allergy Clin Immunol 2015; e-pub ahead of print 19 June 2015; doi:10.1016\/j.jaci.2015.05.008.","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"BFleu2015176_CR9","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","volume":"113","author":"KH Lim","year":"2009","unstructured":"Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009; 113: 5727\u20135736.","journal-title":"Blood"},{"key":"BFleu2015176_CR10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","volume":"124","author":"L Escribano","year":"2009","unstructured":"Escribano L, Alvarez-Twose I, Sanchez-Munoz L, Garcia-Montero A, Nunez R, Almeida J et al. Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol 2009; 124: 514\u2013521.","journal-title":"J Allergy Clin Immunol"},{"key":"BFleu2015176_CR11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/leu.2011.293","volume":"26","author":"C Teodosio","year":"2012","unstructured":"Teodosio C, Garcia-Montero AC, Jara-Acevedo M, Alvarez-Twose I, Sanchez-Munoz L, Almeida J et al. An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis. Leukemia 2012; 26: 951\u2013958.","journal-title":"Leukemia"},{"issue":"8","key":"BFleu2015176_CR12","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/modpathol.2015.72","volume":"28","author":"Maria Jara-Acevedo","year":"2015","unstructured":"Jara-Acevedo M, Teod\u00f3sio C, S\u00e1nchez-Mu\u00f1oz L, Alvarez-Twose I, Mayado A, Caldas C et al. Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications. Mod Pathol 2015; e-pub ahead of print 12 January 2015; doi:10.1038\/modpathol.2015.72.","journal-title":"Modern Pathology"},{"key":"BFleu2015176_CR13","doi-asserted-by":"publisher","first-page":"e76116","DOI":"10.1371\/journal.pone.0076116","volume":"8","author":"A Matito","year":"2013","unstructured":"Matito A, Morgado JM, Alvarez-Twose I, Sanchez-Munoz L, Pedreira CE, Jara-Acevedo M et al. Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome. PLoS One 2013; 8: e76116.","journal-title":"PLoS One"},{"key":"BFleu2015176_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.clim.2005.01.011","volume":"115","author":"K Brockow","year":"2005","unstructured":"Brockow K, Akin C, Huber M, Metcalfe DD . IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis. Clin Immunol 2005; 115: 216\u2013223.","journal-title":"Clin Immunol"},{"key":"BFleu2015176_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1398-9995.2008.01827.x","volume":"64","author":"B Nedoszytko","year":"2009","unstructured":"Nedoszytko B, Niedoszytko M, Lange M, van Doormaal J, Glen J, Zablotna M et al. Interleukin-13 promoter gene polymorphism -1112C\/T is associated with the systemic form of mastocytosis. Allergy 2009; 64: 287\u2013294.","journal-title":"Allergy"},{"key":"BFleu2015176_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jaci.2012.11.008","volume":"132","author":"K Hartmann","year":"2013","unstructured":"Hartmann K, Wagner N, Rabenhorst A, Pflanz L, Leja S, Forster A et al. Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients. J Allergy Clin Immunol 2013; 132: 232\u2013235.","journal-title":"J Allergy Clin Immunol"},{"key":"BFleu2015176_CR17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S0140-6736(96)07524-1","volume":"349","author":"DH Adams","year":"1997","unstructured":"Adams DH, Lloyd AR . Chemokines: leucocyte recruitment and activation cytokines. Lancet 1997; 349: 490\u2013495.","journal-title":"Lancet"},{"key":"BFleu2015176_CR18","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.jaci.2012.12.674","volume":"131","author":"C Teodosio","year":"2013","unstructured":"Teodosio C, Garcia-Montero AC, Jara-Acevedo M, Sanchez-Munoz L, Pedreira CE, Alvarez-Twose I et al. Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis. J Allergy Clin Immunol 2013; 131: 1213\u20131224, e1\u20134.","journal-title":"J Allergy Clin Immunol"},{"key":"BFleu2015176_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","volume":"25","author":"P Valent","year":"2001","unstructured":"Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001; 25: 603\u2013625.","journal-title":"Leuk Res"},{"key":"BFleu2015176_CR20","first-page":"686","volume":"105","author":"HP Horny","year":"2008","unstructured":"Horny HP, Sotlar K, Valent P, Hartmann K . Mastocytosis: a disease of the hematopoietic stem cell. Dtsch Arztebl Int 2008; 105: 686\u2013692.","journal-title":"Dtsch Arztebl Int"},{"key":"BFleu2015176_CR21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","volume":"37","author":"P Valent","year":"2007","unstructured":"Valent P, Akin C, Escribano L, Fodinger M, Hartmann K, Brockow K et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37: 435\u2013453.","journal-title":"Eur J Clin Invest"},{"key":"BFleu2015176_CR22","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/labinvest.3700162","volume":"84","author":"A Rodriguez-Caballero","year":"2004","unstructured":"Rodriguez-Caballero A, Garcia-Montero AC, Bueno C, Almeida J, Varro R, Chen R et al. A new simple whole blood flow cytometry-based method for simultaneous identification of activated cells and quantitative evaluation of cytokines released during activation. Lab Invest 2004; 84: 1387\u20131398.","journal-title":"Lab Invest"},{"key":"BFleu2015176_CR23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","volume":"124","author":"F Rueff","year":"2009","unstructured":"Rueff F, Przybilla B, Bilo MB, Muller U, Scheipl F, Aberer W et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009; 124: 1047\u20131054.","journal-title":"J Allergy Clin Immunol"},{"key":"BFleu2015176_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.iac.2014.02.003","volume":"34","author":"C Akin","year":"2014","unstructured":"Akin C, Valent P . Diagnostic criteria and classification of mastocytosis in 2014. Immunol Allergy Clin North Am 2014; 34: 207\u2013218.","journal-title":"Immunol Allergy Clin North Am"},{"key":"BFleu2015176_CR25","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood.V96.4.1267","volume":"96","author":"C Akin","year":"2000","unstructured":"Akin C, Schwartz LB, Kitoh T, Obayashi H, Worobec AS, Scott LM et al. Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology. Blood 2000; 96: 1267\u20131273.","journal-title":"Blood"},{"key":"BFleu2015176_CR26","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1038\/leu.2013.11","volume":"27","author":"A Pardanani","year":"2013","unstructured":"Pardanani A, Finke C, Abdelrahman RA, Lasho TL, Hanson CA, Tefferi A . Increased circulating IL-2Ralpha (CD25) predicts poor outcome in both indolent and aggressive forms of mastocytosis: a comprehensive cytokine-phenotype study. Leukemia 2013; 27: 1430\u20131433.","journal-title":"Leukemia"},{"key":"BFleu2015176_CR27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000063858","volume":"128","author":"TC Theoharides","year":"2002","unstructured":"Theoharides TC, Boucher W, Spear K . Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol 2002; 128: 344\u2013350.","journal-title":"Int Arch Allergy Immunol"},{"key":"BFleu2015176_CR28","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jaci.2013.06.019","volume":"132","author":"A Rabenhorst","year":"2013","unstructured":"Rabenhorst A, Christopeit B, Leja S, Gerbaulet A, Kleiner S, Forster A et al. Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis. J Allergy Clin Immunol 2013; 132: 1234\u20137 e7.","journal-title":"J Allergy Clin Immunol"},{"key":"BFleu2015176_CR29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4049\/jimmunol.162.1.435","volume":"162","author":"B Nardelli","year":"1999","unstructured":"Nardelli B, Tiffany HL, Bong GW, Yourey PA, Morahan DK, Li Y et al. Characterization of the signal transduction pathway activated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1. J Immunol 1999; 162: 435\u2013444.","journal-title":"J Immunol"},{"key":"BFleu2015176_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nri2691","volume":"10","author":"JE Sims","year":"2010","unstructured":"Sims JE, Smith DE . The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10: 89\u2013102.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2015176_CR31","doi-asserted-by":"publisher","first-page":"e54920","DOI":"10.1371\/journal.pone.0054920","volume":"8","author":"A Essabbani","year":"2013","unstructured":"Essabbani A, Garcia L, Zonetti MJ, Fisco T, Pucci S, Chiocchia G . Exon-skipping strategy by ratio modulation between cytoprotective versus pro-apoptotic clusterin forms increased sensitivity of LNCaP to cell death. PLoS One 2013; 8: e54920.","journal-title":"PLoS One"},{"key":"BFleu2015176_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/0008-5472.CAN-08-2912","volume":"69","author":"IP Trougakos","year":"2009","unstructured":"Trougakos IP, Djeu JY, Gonos ES, Boothman DA . Advances and challenges in basic and translational research on clusterin. Cancer Res 2009; 69: 403\u2013406.","journal-title":"Cancer Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2015176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015176","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T03:19:50Z","timestamp":1691810390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2015176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,8]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["BFleu2015176"],"URL":"https:\/\/doi.org\/10.1038\/leu.2015.176","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,8]]},"assertion":[{"value":"24 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}